logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Ji‐Youn Han

national cancer center

69H指数
481论文数
2.5W被引数
收录论文 112
发表时间
logo
Landscape of cancer genomics and precision oncology in Japan, South Korea, China, and Australia日本、韩国、中国和澳大利亚癌症基因组学与精准肿瘤学的现状
errLancet Regional Health-Western Pacific
IF8.1
err2026-09-10
err0
errOAAI
errHideaki Bando; Hirokazu Okayama; Yoon Jung Chang; Jinpu Yu; Sean M. Grimmond; Sun-Young Kong; Xin Hu; Nikolajs Zeps; Ji-Youn Han; Jong-Il Kim; Kyosuke Seguchi; Masataka Amisaki; Yasutoshi Sakamoto; Takao Fujisawa; Riu Yamashita; Kazuto Kato; Koji Kono; Amber Johns; Takayuki Yoshino
err分享
err收藏
Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives生物学、检测和管理意外性肺结节：靶向治疗的新兴作用。当前文献回顾与未来展望
errLung Cancer
IF4.4
err2026-08-03
err0
PREAI
errRoss A. Soo; Ji-Youn Han; James Chung-Man Ho; Calvin S.H. Ng; Lynette L.S. Teo; Elaine Shum; Sanjay Popat
err分享
err收藏
Author Correction: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial作者勘误：靶向SEZ6的抗体药物偶联物ABBV-706在晚期小细胞肺癌和实体瘤中的研究：一项1期临床试验
errNature Medicine
IF50
err2026-06-29
err0
errOAAI
errLauren Averett Byers; Byoung Chul Cho; Alissa J. Cooper; Anne C. Chiang; Ji-Youn Han; Muhammad Furqan; Afshin Dowlati; Daniel Morgensztern; Kyriakos P. Papadopoulos; Noura J. Choudhury; María Vieito; Jair Bar; Joo-Hang Kim; Wallace Akerley; Tae Min Kim; Young-Chul Kim; Luis Paz-Ares; Myung-Ju Ahn; Hiroshi Yokouchi; Darius Meiman; Wijith Munasinghe; Oluwadamilola Ogunyankin; Nadine Jahchan; Song Wang; Cristiano Ferlini; Randy R. Robinson; Frederick J. Kohlhapp; Tammy Palenski; Guillermo Rivell; Pooja Hingorani; Sreenivasa Chandana
err分享
err收藏
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial靶向SEZ6抗体偶联药物ABBV-706在晚期小细胞肺癌和实体瘤中的I期临床试验
errNature Medicine
IF50
err2026-06-01
err0
errOAAI
errLauren Averett Byers; Byoung Chul Cho; Alissa J. Cooper; Anne C. Chiang; Ji-Youn Han; Muhammad Furqan; Afshin Dowlati; Daniel Morgensztern; Kyriakos P. Papadopoulos; Noura J. Choudhury; María Vieito; Jair Bar; Joo-Hang Kim; Wallace Akerley; Tae Min Kim; Young-Chul Kim; Luis Paz-Ares; Myung-Ju Ahn; Hiroshi Yokouchi; Darius Meiman; Wijith Munasinghe; Oluwadamilola Ogunyankin; Nadine Jahchan; Song Wang; Cristiano Ferlini; Randy R. Robinson; Frederick J. Kohlhapp; Tammy Palenski; Guillermo Rivell; Pooja Hingorani; Sreenivasa Chandana
err分享
err收藏
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study奥罗玛西布（olomorasib）对KRAS G12C突变型晚期实体瘤的泛瘤活性：一项首次人体研究
errNature Communications
IF15.7
err2026-03-12
err0
errOAAI
errYonina R. Murciano-Goroff; Antoine Hollebecque; Rebecca S. Heist; Philippe A. Cassier; Ji-Youn Han; So Yeon Kim; Joshua K. Sabari; Diego Tosi; Adrian Sacher; Timothy F. Burns; Toshio Shimizu; Natraj Reddy Ammakkanavar; Alexander Spira; Carlos Gomez-Roca; Amita Patnaik; Rasha Cosman; J. Nicholas Bodor; Misako Nagasaka; Arthur Xintian You; Samuel C. McNeely; Raimund Peter; Aaron Fink; Aaron Chen; Geoffrey R. Oxnard; Melinda D. Willard; Yasutoshi Kuboki; Takafumi Koyama
err分享
err收藏
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial
errFUTURE ONCOLOGY
IF2.6
err2025-12-01
err0
PREAI
errAhn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia
err分享
err收藏
Efficacy and Safety of Olomorasib in Combination with Pembrolizumab in Treatment of Patients with KRAS G12C-Mutant Advanced NSCLC奥罗莫西布与帕博利珠单抗联合治疗KRAS G12C突变型晚期非小细胞肺癌的疗效与安全性
errJournal of Thoracic Oncology
IF20.8
err2025-11-29
err0
PREAI
errTimothy F. Burns; Natraj Reddy Ammakkanavar; Antoine Hollebecque; Dae Ho Lee; Takafumi Koyama; Philippe A. Cassier; Antoine Italiano; Ji-Youn Han; Nimit Singhal; Shinji Takeuchi; Rebecca S. Heist; Dustin Deming; Alexander Spira; Quincy Chu; Adrian Sacher; Yutaka Fujiwara; Michael J. Chisamore; Arthur Xintian You; Samuel C. McNeely; Aaron Fink
err分享
err收藏
Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung Cancer亚洲亚组分析：tarlatamab在先前治疗过的的小细胞肺癌的DeLLphi-301研究第二阶段中的患者分析
errOncology and Therapy
IF3.2
err2025-09-04
err0
errOAAI
errMyung-Ju Ahn; Byoung Chul Cho; Kadoaki Ohashi; Hiroki Izumi; Jong-Seok Lee; Ji-Youn Han; Chi-Lu Chiang; Shuang Huang; Ali Hamidi; Sujoy Mukherjee; Krista Lin Xu; Hiraoki Akamatsu
err分享
err收藏
Central nervous system outcomes of lazertinib treatment in EGFR-mutated advanced NSCLC: Pooled analysis from LASER201 and LASER301拉泽替尼治疗EGFR突变晚期NSCLC的神经系统结局：LASER201和LASER301的合并分析
errClinical Lung Cancer
IF3.3
err2025-09-01
err0
PREAI
errJames CH Yang; Myung-Ju Ahn; Joo-Hang Kim; Yun-Gyoo Lee; Ji-Youn Han; Ki Hyeong Lee; Anastasia Zimina; Dong-Wan Kim; Kyung-Hee Lee; Sung Sook Lee; Chun Sen Lim; Yueh Ni Lim; Young Joo Min; Sergey Orlov; Youngjoo Lee; YuKyung Kim; Mi-Jung Kwon; Hana Lee; Hyeonchae Cho; Byoung Chul Cho
err分享
err收藏
Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor–tyrosine kinase inhibitor resistance subclones对难治性肺癌进行纵向药基因组学分析，以识别表皮生长因子受体–酪氨酸激酶抑制剂耐药亚克隆的治疗候选物
errExperimental & Molecular Medicine
IF12.9
err2025-07-04
err0
errOAAI
errNamhee Yu; Mihwa Hwang; Beung Chul Ahn; Youngjoo Lee; Sehwa Hong; Hanna Sim; Bo Ram Song; Sunshin Kim; Charny Park; Ji-Youn Han
err分享
err收藏
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS StudyAmivantamab在晚期NSCLC和MET外显子14跳跃突变参与者中的应用: CHRYSALIS研究的最终结果
errJournal of Thoracic Oncology
IF20.8
err2025-05-16
err0
PREAI
errMatthew G. Krebs; Byoung Chul Cho; Sandrine Hiret; Ji-Youn Han; Ki Hyeong Lee; Casilda Llácer Pérez; Filippo De Braud; Eric B. Haura; Rachel E. Sanborn; James Chih-Hsin Yang; Catherine A. Shu; Koichi Goto; Makoto Nishio; Jun Zhao; Zhijie Wang; Pascale Tomasini; Enriqueta Felip; Jonathan W. Goldman; Sai-Hong Ignatius Ou; Michael Boyer; Grace Gao; Siyang Qu; Joshua C. Curtin; Xuesong Lyu; Robert W. Schnepp; Priya Kim; Meena Thayu; Roland E. Knoblauch; Patricia Lorenzini; Mahadi Baig; Alexander I. Spira; Natasha B. Leighl
err分享
err收藏
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial一项关于阿替利珠单抗、贝伐珠单抗和化疗在获得性耐药的EGFR突变非小细胞肺癌中的随机非对照II期研究——ETOP 15-19 ABC-lung试验
errLUNG CANCER
IF4.4
err2025-04-01
err0
PREAI
errSoo, R. A.; Vervita, K.; Fruh, M.; Cho, B. C.; Majem, M.; Abreu, D. Rodriguez; Ribi, K.; Callejo, A.; Moran, T.; Gomez, M. Domine; Provencio, M.; Addeo, A.; Han, J. Y.; Granados, A. L. Ortega; Reck, M.; Blasco, A.; Campelo, R. Garcia; Gonzalez, M. A. Sala; Britschgi, C.; Roschitzki-Voser, H.; Ruepp, B.; Gasca-Ruchti, A.; Haberecker, M.; Dafni, U.; Peters, S.; Stahel, R. A.
err分享
err收藏
TROPION-Lung07: Phase III study of Dato-DXd plus pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancerTROPION-Lung07: dato-dxd联合pembrolizumab ± 铂类化疗作为1L治疗晚期非小细胞肺癌的III期研究
errFUTURE ONCOLOGY
IF2.6
err2024-10-29
err1
errOAAI
errOkamoto, Isamu; Kuyama, Shoichi; Girard, Nicolas; Lu, Shun; Franke, Fabio; Li, Ziming; Danchaivijitr, Pongwut; Han, Ji-Youn; Sun, Jong-Mu; Sugawara, Shunichi; Pan, Edward; Ren, Natalie; Chen, Aiying; Rajagopalan, Rachana; Lisberg, Aaron E.
err分享
err收藏
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study1/2期LASER201研究中使用拉泽替尼治疗的EGFR T790M-positive晚期非小细胞肺癌患者的更新的总生存期和ctDNA分析
errBMC MEDICINE
IF8.3
err2024-10-08
err0
errOAAI
errHan, Ji-Youn; Ahn, Myung-Ju; Lee, Ki Hyeong; Lee, Yun-Gyoo; Kim, Dong-Wan; Min, Young Joo; Kim, Sang-We; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Na Mi; Jang, Hyun Woo; Han, Heewon; Park, Hyejoo; Lee, Jieon; Cho, Byoung Chul
err分享
err收藏
Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-tyrosine kinase inhibitor (TKI), in patients with 3rd generation EGFR-TKI resistance in EGFR mutated advanced/metastatic non-small cell lung cancer (NSCLC)
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-10-01
err0
PREAI
errLim, S. M.; Cho, B. C.; Han, J. Y.; Kim, S. W.; Lee, K. H.; Nagasaka, M.; Jo, A.; Seah, E.; Kim, C.; Reungwetwattana, T.
err分享
err收藏
Detailed characterization of combination treatment with MET inhibitor plus EGFR inhibitor in EGFR-mutant and MET-amplified non-small cell lung cancer
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2024-10-01
err0
errOAAI
errLee, Youngjoo; Park, Seog-Yun; Lee, Geon Kook; Lim, Hyun-Ju; Choi, Yu-Ra; Kim, Jaemin; Han, Ji-Youn
err分享
err收藏
Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma
errEXPERIMENTAL AND MOLECULAR MEDICINE
IF12.9
err2024-09-19
err0
errOAAI
errKim, Hyondeog; Lee, Wonyeop; Kim, Youngwook; Lee, Sang-Jin; Choi, Wonyoung; Lee, Geon Kook; Park, Seung-Jin; Ju, Shinyeong; Kim, Seon-Young; Lee, Cheolju; Han, Ji-Youn
err分享
err收藏
ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial
errCLINICAL CANCER RESEARCH
IF10.2
err2024-09-09
err0
PREAI
errSoo, Ross A.; Dafni, Urania; Han, Ji-Youn; Cho, Byoung Chul; Nadal, Ernest; Yeo, Chong Ming; Carcereny, Enric; de Castro, Javier; Sala, Maria Angeles; Coate, Linda; Provencio, Mariano; Britschgi, Christian; Vagenknecht, Patrick; Dimopoulou, Georgia; Kammler, Roswitha; Finn, Stephen P.; Peters, Solange; Stahel, Rolf A.
err分享
err收藏
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2024-07-01
err0
errOAAI
errSolomon, Benjamin J.; Dagogo-Jack, Ibiayi; Lee, Se-Hoon; Boyer, Michael J.; Ramalingam, Suresh S.; Carcereny, Enric; Felip, Enriqueta; Han, Ji-Youn; Hida, Toyoaki; Hughes, Brett G. M.; Kim, Sang -We; Nishio, Makoto; Seto, Takashi; Okamoto, Tatsuro; Zhang, Xiaoxi; Martini, Jean -Francois; Wang, Erjian; De Beukelaer, Steven; Bauer, Todd M.
err分享
err收藏
Seasonal influences on the efficacy of anti-programmed cell death (ligand) 1 inhibitors in lung cancer
errCANCER
IF5.1
err2024-06-28
err0
PREAI
errCho, Hyunsoon; Kwon, Hoejun; Kim, Se Hyun; Ahn, Hyung-Min; Choi, Beom K.; Lee, Geon Kook; Park, Seog-Yun; Lim, Hyun-ju; Hwang, Jung-Ah; Lim, Jiyeon; Han, Ji-Youn; Lee, Youngjoo
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Pasi A. Jänne
H 指数: 163 · 论文数: 2.3K
P
Patrick Y. Wen
H 指数: 145 · 论文数: 1.9K
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
R
Roy S. Herbst
H 指数: 134 · 论文数: 1.3K
查看更多